Biodesix, Inc. (BDSX)

USD 0.61

(14.15%)

Long Term Debt Summary of Biodesix, Inc.

  • Biodesix, Inc.'s latest annual long term debt in 2023 was 35.22 Million USD , up 16.42% from previous year.
  • Biodesix, Inc.'s latest quarterly long term debt in 2024 Q3 was 61.3 Million USD , up 0.85% from previous quarter.
  • Biodesix, Inc. reported annual long term debt of 30.25 Million USD in 2022, up 202.79% from previous year.
  • Biodesix, Inc. reported annual long term debt of 9.99 Million USD in 2021, down -37.25% from previous year.
  • Biodesix, Inc. reported quarterly long term debt of 35.8 Million USD for 2024 Q2, up 0.83% from previous quarter.
  • Biodesix, Inc. reported quarterly long term debt of 35.51 Million USD for 2024 Q1, up 0.81% from previous quarter.

Annual Long Term Debt Chart of Biodesix, Inc. (2023 - 2018)

Historical Annual Long Term Debt of Biodesix, Inc. (2023 - 2018)

Year Long Term Debt Long Term Debt Growth
2023 35.22 Million USD 16.42%
2022 30.25 Million USD 202.79%
2021 9.99 Million USD -37.25%
2020 15.92 Million USD -33.12%
2019 23.81 Million USD 3.09%
2018 23.09 Million USD 0.0%

Peer Long Term Debt Comparison of Biodesix, Inc.

Name Long Term Debt Long Term Debt Difference
Aspira Women's Health Inc. 1.43 Million USD -2363.287%
bioAffinity Technologies, Inc. 1.11 Million USD -3049.397%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -43214.397%
Standard BioTools Inc. 3.98 Million USD -784.384%
Inotiv, Inc. 399.4 Million USD 91.181%
Prenetics Global Limited 867.21 Thousand USD -3961.853%
Neuronetics, Inc. 59.28 Million USD 40.582%
Star Equity Holdings, Inc. 1.14 Million USD -2976.419%
Castle Biosciences, Inc. 14.19 Million USD -148.098%
Psychemedics Corporation 945 Thousand USD -3627.513%
RadNet, Inc. 812.06 Million USD 95.662%
Exact Sciences Corporation 2.47 Billion USD 98.577%
IDEXX Laboratories, Inc. 622.88 Million USD 94.345%
iSpecimen Inc. 29.13 Thousand USD -120823.447%
OpGen, Inc. 2.02 Million USD -1642.418%
Exagen Inc. 19.23 Million USD -83.168%
Bionano Genomics, Inc. 7.17 Million USD -390.941%
CareDx, Inc 28.27 Million USD -24.567%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 55.509%
Guardant Health, Inc. 1.13 Billion USD 96.91%
BioNexus Gene Lab Corp. 98.76 Thousand USD -35566.191%
Precipio, Inc. 106 Thousand USD -33131.132%
Natera, Inc. 282.94 Million USD 87.551%
Fulgent Genetics, Inc. 10.11 Million USD -248.383%
Sera Prognostics, Inc. 840 Thousand USD -4093.452%
23andMe Holding Co. 67.84 Million USD 48.08%
OPKO Health, Inc. 222.03 Million USD 84.135%
Personalis, Inc. 1.23 Million USD -2754.538%
Aclaris Therapeutics, Inc. 3.07 Million USD -1045.901%
Applied DNA Sciences, Inc. 739.16 Thousand USD -4665.532%
T2 Biosystems, Inc. 6.59 Million USD -433.874%
Neogen Corporation 888.39 Million USD 96.035%
Myriad Genetics, Inc. 130.9 Million USD 73.09%
ICON Public Limited Company 3.66 Billion USD 99.039%
NeoGenomics, Inc. 606.06 Million USD 94.188%
Star Equity Holdings, Inc. 1.14 Million USD -2976.419%
MDxHealth SA 35.56 Million USD 0.953%
Prenetics Global Limited 867.21 Thousand USD -3961.853%
Illumina, Inc. 1.48 Billion USD 97.634%
DarioHealth Corp. 24.59 Million USD -43.243%
ENDRA Life Sciences Inc. 192.06 Thousand USD -18240.432%
Medpace Holdings, Inc. 142.12 Million USD 75.215%
Mainz Biomed B.V. 2.19 Million USD -1504.134%
Trinity Biotech plc 54.65 Million USD 35.546%
Sotera Health Company 2.22 Billion USD 98.416%
bioAffinity Technologies, Inc. 1.11 Million USD -3049.397%